-
-
-
-
-
-
-
Alpha Cognition Inc. (Nasdaq: ACOG) Announces Participation in Key September Investor Conferences
-
-
-
-
-
-
-
Alpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating Overview
-
-
-
-
-
-
-
Alpha Cognition (ACOG) Secures Additional U.S. Patent for ZUNVEYL (benzgalantamine) in the Treatment of Mild to Moderate Alzheimer’s disease
-
-
-
-
-
-
-
Alpha Cognition Announces Partial Exercise of Over-allotment Option
-
-
-
-
-
-
-
Form S-1 Alpha Cognition Inc.
-
-
-
-
-
-
-
Alpha Cognition Announces Financial Results for the Second Quarter and Six Months Ended June 2024 and Provides Corporate Update
-
-
-
-
-
-
-
Form S-1 Alpha Cognition Inc.
66,598 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

